Lumos Diagnostics Holdings Limited (ASX:LDX)

Revenue by Segment

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018
Being The Provision of Point of Care Diagnostics Goods and Services	12.40M	11.13M	10.54M	11.63M	18.85M
Being The Provision of Point of Care Diagnostics Goods and Services Growth	11.40%	5.66%	-9.42%	-38.32%	225.25%
Total	12.40M	11.13M	10.54M	11.63M	18.85M
Total Growth	11.40%	5.66%	-9.42%	-38.32%	225.25%

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018
United States	12.40M	11.13M	10.54M	11.14M	17.70M
United States Growth	11.40%	5.66%	-5.46%	-37.05%	411.26%
Australia	-	-	-	487.00K	1.15M
Australia Growth	-	-	-	-57.73%	-50.65%
Total	12.40M	11.13M	10.54M	11.63M	18.85M
Total Growth	11.40%	5.66%	-9.42%	-38.32%	225.25%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 18, 2026

Data Sources Report a data error